1. Home
  2. ANPA vs TECX Comparison

ANPA vs TECX Comparison

Compare ANPA & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANPA

Rich Sparkle Holdings Limited Ordinary Shares

N/A

Current Price

$22.50

Market Cap

300.0M

Sector

N/A

ML Signal

N/A

Logo Tectonic Therapeutic Inc. Common Stock

TECX

Tectonic Therapeutic Inc. Common Stock

HOLD

Current Price

$19.82

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANPA
TECX
Founded
2016
2019
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
300.0M
359.0M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
ANPA
TECX
Price
$22.50
$19.82
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$81.20
AVG Volume (30 Days)
15.7K
328.2K
Earning Date
09-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
N/A
Revenue
$5,832,684.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$390.11
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.80
$13.70
52 Week High
$54.75
$61.07

Technical Indicators

Market Signals
Indicator
ANPA
TECX
Relative Strength Index (RSI) N/A 52.30
Support Level N/A $18.60
Resistance Level N/A $21.50
Average True Range (ATR) 0.00 1.65
MACD 0.00 -0.07
Stochastic Oscillator 0.00 47.69

Price Performance

Historical Comparison
ANPA
TECX

About ANPA Rich Sparkle Holdings Limited Ordinary Shares

Rich Sparkle Holdings Ltd is financial printing and corporate services provider which engaged in designing and printing financial print materials in Hong Kong. It service portfolio covers a myriad of deliverables, mainly including listing documents, financial reports, fund documents, circulars and announcements. The company's core business includes (i) financial printing services such as printing, typesetting and translation, (ii) advisory services including Environmental, Social and Governance Report and (iii) other services. Key revenue is generated from Financial printing services.

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: